Medicare Enrolled
Dr. Anirudha Dasgupta, MD
Hematology & Oncology · Kingwood, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dasgupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dasgupta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dasgupta
Dr. Anirudha Dasgupta is a hematology & oncology specialist in Kingwood, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Dasgupta performed 69,036 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dasgupta received a total of $47,189 from 102 pharmaceutical and/or device companies across 1129 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dasgupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 13% volume in TX
$47,189 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗69,036
Medicare services
Top 13% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
40,500 | $1 | $3 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
10,800 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
7,470 | $2 | $8 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,500 | $0 | $0 |
| MRI contrast dye injection (gadoterate) Administration of gadoterate meglumine, a contrast agent, in a 0.1 ml dose. |
2,400 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
910 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 712 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
487 | $93 | $346 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
328 | $18 | $63 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
314 | $11 | $38 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
304 | $22 | $82 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
251 | $63 | $243 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
164 | $49 | $179 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
159 | $98 | $374 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
129 | $17 | $73 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
93 | $61 | $185 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
77 | $22 | $80 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
57 | $2 | $7 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
54 | $1,160 | $5,368 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 49 | $110 | $295 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
49 | $1 | $3 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $118 | $449 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
42 | $25 | $92 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
39 | $91 | $349 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
28 | $57 | $425 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $135 | $483 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $18 | $62 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
14 | $60 | $192 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $125 | $513 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $124 | $478 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
59.7% high complexity
38.1% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,189
Total received (2018-2024)
Avg $6,741/year across 7 years
Top 13% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
102
Companies
1,129
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,737
2023
$2,869
2022
$5,203
2021
$6,851
2020
$4,858
2019
$6,634
2018
$3,036
Payments by company (2024)
Karyopharm Therapeutics Inc.
$13,441
AstraZeneca Pharmaceuticals LP
$532
Celgene Corporation
$335
Daiichi Sankyo Inc.
$326
PFIZER INC.
$277
Novartis Pharmaceuticals Corporation
$253
Rigel Pharmaceuticals, Inc.
$180
E.R. Squibb & Sons, L.L.C.
$173
SOBI, INC
$172
GlaxoSmithKline, LLC.
$146
Takeda Pharmaceuticals U.S.A., Inc.
$143
Alexion Pharmaceuticals, Inc.
$142
Incyte Corporation
$121
Gilead Sciences, Inc.
$107
Astellas Pharma US Inc
$90
Tempus AI, Inc
$87
SpringWorks Therapeutics, Inc.
$87
Deciphera Pharmaceuticals Inc.
$86
Lilly USA, LLC
$86
Iovance Biotherapeutics, Inc.
$83
JAZZ PHARMACEUTICALS INC.
$81
Eisai Inc.
$74
Regeneron Healthcare Solutions, Inc.
$72
ABBVIE INC.
$71
Merck Sharp & Dohme LLC
$71
TerSera Therapeutics LLC
$70
TAIHO ONCOLOGY, INC.
$52
GENZYME CORPORATION
$51
PharmaEssentia USA Corporation
$50
Boston Scientific Corporation
$43
RECORDATI_RARE_DISEASES_INC.
$29
Mirati Therapeutics, Inc.
$24
Pharmacosmos Therapeutics Inc.
$23
Kyowa Kirin, Inc.
$23
Stemline Therapeutics Inc.
$20
Exelixis Inc.
$20
ADC Therapeutics America, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Secura Bio, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$15
Adaptive Biotechnologies Corporation
$14
Top 3 companies account for 80.7% of 2024 payments
All-time payments by company (2018-2024) ›
Karyopharm Therapeutics Inc.
$13,567
AstraZeneca Pharmaceuticals LP
$4,897
PFIZER INC.
$2,957
ARRAY BIOPHARMA INC
$2,015
Bayer HealthCare Pharmaceuticals Inc.
$1,938
MorphoSys, US Inc.
$1,852
Exelixis Inc.
$1,808
E.R. Squibb & Sons, L.L.C.
$1,617
Novartis Pharmaceuticals Corporation
$1,461
Amgen Inc.
$1,215
GlaxoSmithKline, LLC.
$943
Celgene Corporation
$883
Merck Sharp & Dohme Corporation
$844
Daiichi Sankyo Inc.
$580
Takeda Pharmaceuticals U.S.A., Inc.
$556
GENZYME CORPORATION
$521
Janssen Biotech, Inc.
$519
Lilly USA, LLC
$490
Gilead Sciences, Inc.
$465
Genentech USA, Inc.
$444
Seagen Inc.
$371
Boehringer Ingelheim Pharmaceuticals, Inc.
$358
Incyte Corporation
$309
Astellas Pharma US Inc
$307
EISAI INC.
$306
Eisai Inc.
$262
Merck Sharp & Dohme LLC
$255
Taiho Oncology, Inc.
$250
Rigel Pharmaceuticals, Inc.
$247
SOBI, INC
$246
BeiGene USA, Inc.
$224
Regeneron Healthcare Solutions, Inc.
$199
Alexion Pharmaceuticals, Inc.
$195
AVEO Pharmaceuticals, Inc.
$181
Ipsen Biopharmaceuticals, Inc
$177
Pharmacyclics LLC, An AbbVie Company
$157
TerSera Therapeutics LLC
$154
Dova Pharmaceuticals
$142
Janssen Pharmaceuticals, Inc
$139
CTI BioPharma Corp.
$130
Deciphera Pharmaceuticals Inc.
$130
Puma Biotechnology, Inc.
$127
ABBVIE INC.
$107
JAZZ PHARMACEUTICALS INC.
$105
TAIHO ONCOLOGY, INC.
$102
Agios Pharmaceuticals, Inc.
$95
Tempus AI, Inc
$87
SpringWorks Therapeutics, Inc.
$87
SANOFI-AVENTIS U.S. LLC
$86
Iovance Biotherapeutics, Inc.
$83
Foundation Medicine, Inc.
$81
Boston Scientific Corporation
$80
Blueprint Medicines Corporation
$77
Myovant Sciences Inc.
$75
AbbVie Inc.
$69
PUMA BIOTECHNOLOGY, INC.
$69
TESARO, Inc.
$69
Teva Pharmaceuticals USA, Inc.
$68
Sirtex Medical Inc
$65
Kyowa Kirin, Inc.
$59
EMD Serono, Inc.
$58
Sobi, Inc
$57
Seattle Genetics, Inc.
$57
Kite Pharma, Inc.
$52
PharmaEssentia USA Corporation
$50
Octapharma USA, Inc.
$46
Jazz Pharmaceuticals Inc.
$46
Adaptive Biotechnologies Corporation
$45
Bayer Healthcare Pharmaceuticals Inc.
$45
Stemline Therapeutics Inc.
$44
Dendreon Pharmaceuticals LLC
$42
Alnylam Pharmaceuticals Inc.
$41
Acceleron Pharma, Inc.
$41
BOSTON SCIENTIFIC CORPORATION
$40
Mirati Therapeutics, Inc.
$40
Apellis Pharmaceuticals, Inc.
$36
Pharmacosmos Therapeutics Inc.
$36
Verastem, Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$29
Immunocore Limited
$29
AMAG Pharmaceuticals, Inc.
$27
Blue Earth Diagnostics Limited
$26
Inari Medical, Inc.
$26
Allergan Inc.
$24
Nestle HealthCare Nutrition Inc.
$24
Spectrum Pharmaceuticals Inc.
$23
MEDIVATION FIELD SOLUTIONS LLC
$22
Abbott Laboratories
$21
R-Pharm US LLC
$21
Pharmacyclics LLC, an AbbVie Company
$20
ADC Therapeutics America, Inc.
$19
G1 Therapeutics, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Secura Bio, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$16
Servier Pharmaceuticals LLC
$15
Array BioPharma Inc.
$15
Clovis Oncology, Inc.
$15
Sun Pharmaceutical Industries Inc.
$14
Sumitomo Pharma America, Inc.
$14
Genentech, Inc.
$13
Heron Therapeutics, Inc.
$12
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · Axumin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARDIOMEMS · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · Crysvita · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · Enhertu · Erleada · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LOKELMA · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Orserdu · PADCEV · PANZYGA · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · S · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SYLVANT · SYNAGIS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEFLARO · THERASPHERE · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · Truxima · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vectibix · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
41
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
KINGWOOD PINES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dasgupta is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dasgupta experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Dasgupta performed 40,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dasgupta receive payments from pharmaceutical companies?
Yes. Dr. Dasgupta received a total of $47,189 from 102 companies across 1,129 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dasgupta's costs compare to other hematology & oncology specialists in Kingwood?
Dr. Dasgupta's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dasgupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Kingwood
Browse hematology & oncology specialists in Kingwood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology